References
- Así vamos en salud. (2017). el índice Así Vamos en Salud – indicadores en salud normatividad derechos. Retrieved July 13, 2020, from https://www.asivamosensalud.org/sites/default/files/resumen_ejecutivo_indices_avs_2017_0.pdf
- Awad, G. H., Sagrestano, L. M., Kittleson, M. J., & Sarvela, P. D. (2004). Development of a measure of barriers to HIV testing among individuals at high risk. AIDS Education and Prevention, 16(2), 115–125. https://doi.org/https://doi.org/10.1521/aeap.16.2.115.29397
- Barocas, J. A., Brennan, M. B., Hull, S. J., Stokes, S., Fangman, J. J., & Westergaard, R. P. (2014). Barriers and facilitators of hepatitis C screening among people who inject drugs: A multi-city, mixed-methods study. Harm Reduction Journal, 11(1), 1. https://doi.org/https://doi.org/10.1186/1477-7517-11-1
- Berbesi, D., Segura, A., & Montoya, L. (2014). Cross-sectional study of HIV prevalence and the characteristics of injecting drug users in Colombia. Journal of Substance Use, 19(5), 364–367. https://doi.org/https://doi.org/10.3109/14659891.2013.824037
- Borda, J. P., Friedman, H., Buitrago, J., Isaza, M., Herrera, P., Krawczyk, N., & Tofighi, B. (2021). Barriers to treatment for opioid use disorder in Colombia. Journal of Substance Use, 1–7. https://doi.org/https://doi.org/10.1080/14659891.2021.1875070
- Davis, A., McCrimmon, T., Dasgupta, A., Gilbert, L., Terlikbayeva, A., Hunt, T., Primbetova, S., Wu, E., Darisheva, M., & El-Bassel, N. (2018). Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan. International Journal of Drug Policy, 62, 43–50. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.08.014
- Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., Lynskey, M., Griffiths, P., Mattick, R. P., Hickman, M., & Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. The Lancet Global Health, 5(12), e1192–e1207. https://doi.org/https://doi.org/10.1016/S2214-109X(17)30375-3
- Departamento Administrativo Nacional de Estadística (DANE). (2019). Encuesta nacional de consumo de sustancias psicoactivas – ENCSPA.
- Gomez-Aldana, A. J., Tapias, M., & Rosselli, D. (2020). Colombian experience in the management of hepatitis C. In Liver international (Vol. 40(12), p. 3143). Blackwell Publishing. https://doi.org/https://doi.org/10.1111/liv.14582
- Grebely, J., Dore, G. J., Morin, S., Rockstroh, J. K., & Klein, M. B. (2017). Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there. Journal of the International AIDS Society, 20(1), 22146. https://doi.org/https://doi.org/10.7448/IAS.20.1.22146
- Januraga, P. P., Reekie, J., Mulyani, T., Lestari, B. W., Iskandar, S., Wisaksana, R., Kusmayanti, N. A., Subronto, Y. W., Widyanthini, D. N., Wirawan, D. N., Wongso, L. V., Sudewo, A. G., Sukmaningrum, E., Nisa, T., Prabowo, B. R., Law, M., Cooper, D. A., & Kaldor, J. M. (2018). The cascade of HIV care among key populations in Indonesia: A prospective cohort study. The Lancet HIV, 5(10), e560–e568. https://doi.org/https://doi.org/10.1016/S2352-3018(18)30148-6
- Kalichman, S. C., Catz, S., & Ramachandran, B. (1999). Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. Journal of the National Medical Association, 91(8), 439–446.
- Larney, S., Peacock, A., Leung, J., Colledge, S., Hickman, M., Vickerman, P., Grebely, J., Dumchev, K. V., Griffiths, P., Hines, L., Cunningham, E. B., Mattick, R. P., Lynskey, M., Marsden, J., Strang, J., & Degenhardt, L. (2017). Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: A systematic review. The Lancet Global Health, 5(12), e1208–e1220. https://doi.org/https://doi.org/10.1016/S2214-109X(17)30373-X
- Mateu-Gelabert, P., Harris, S., Berbesi, D., Segura Cardona, Á. M., Montoya Vélez, L. P., Mejía Motta, I. E., Jessell, L., Guarino, H., & Friedman, S. R. (2016). Heroin use and injection risk behaviors in Colombia: Implications for HIV/AIDS prevention. Substance Use and Misuse, 51(2), 230–240. https://doi.org/https://doi.org/10.3109/10826084.2015.1092989
- Mecanismo coordinador de País, & Fondo Mundia del lucha contre el SIDA, la Tuberculosis y la Malaria. (2016). Informe de resultados comportamiento sexual y prevalencia de VIH en hombres que tienen relaciones sexuales con hombres en siete ciudades de Colombia (Bogotá, Medellín, Cali, Barranquilla, Cúcuta, Pereira y Cartagena).
- Mecanismo de Coordinación de País, & Fondo Mundia del lucha contre el SIDA, la Tuberculosis y la Malaria. (2013). Resultados del estudio comportamiento sexual y prevalencia de infección por VIH de las mujeres trabajadoras sexuales en cinco ciudades de colombia, 2012.
- Metzger, D. S. (1993). Risk assessment battery (RAB) 1993.
- Ministerio de Justicia y del Derecho – Observatorio de Drogas de Colombia. (2015). La heroína en Colombia, Producción, uso e impacto en la salud pública – Análisis de la evidencia y recomendaciones de política. https://doi.org/https://doi.org/10.1017/CBO9781107415324.004
- Ministerio de Salud y Protección Social. (2015). Guía para la reducción de daños y la prevención del VIH y otras ITS asociadas a la inyección de drogas en Colombia.
- Toro-Tobón, D., Berbesi-Fernandez, D., Mateu-Galabert, P., Segura-Cardona, Á. M., & Montoya-Vélez, L. P. (2018). Prevalence of hepatitis C virus in young people who inject drugs in four Colombian cities: A cross-sectional study using Respondent Driven Sampling. International Journal of Drug Policy, 60, 56–65. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.07.002
- Walsh, N., & Maher, L. (2013). HIV and HCV among people who inject drugs in Central Asia. Drug and Alcohol Dependence, 132(Suppl. 1), S37–S40. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2013.06.030
- World Health Organization. (2016). Global health sector strategy on viral hepatitis 2016–2021. https://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf?sequence=1
- World Health Organization. (n.d.). Process of translation and adaptation of instruments. Retrieved June 3, 2020, from https://www.who.int/substance_abuse/research_tools/translation/en/